A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, and effective immunotherapies, ...
Jan 22, 2026
0
15
Advances in lung cancer treatment have changed survival in ways that were unimaginable even a decade ago. Targeted drugs, immunotherapies, and emerging antibody–drug conjugates are helping many patients live longer—and live ...
Jan 21, 2026
0
10
UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer immunotherapy treatment in mice and can now be made into a drug for testing ...
Jan 14, 2026
0
50
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of vaccines and immune checkpoint inhibitor drugs, but it's not always clear which therapy is inducing ...
Jan 12, 2026
0
10
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target tumors. Despite their initial clinical success, many patients eventually experience diminished therapeutic ...
Dec 29, 2025
0
21
Published today in Clinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of Oncology (VHIO), which forms part of the Vall d'Hebron Campus, underscore the efficacy of analyzing ...
Dec 17, 2025
0
9
Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make cancer immunotherapy work for many more patients.
Dec 16, 2025
0
47
Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale description of its risk factors ...
Dec 14, 2025
0
17
Immunotherapy has been one of the most promising advancements in cancer treatment. However, consistency in immunotherapy treatment effectiveness remains a formidable challenge. Now, Cancer Center at Illinois member Kun Wang, ...
Oct 22, 2025
0
27
A new study has identified a potential new target for treating triple-negative breast cancer, one of the most aggressive forms of breast cancer, which still has very few therapeutic options available. The study was carried ...
Sep 17, 2025
0
13
